TL;DR
New insights are provided to provide a mechanistic rationale for the clinical integration of A. membranaceus as an adjuvant therapy in gynecological and breast cancers, to bridge traditional Chinese medicine with contemporary pharmacology, and to support the development of individualized, integrative therapeutic strategies for breast, ovarian and cervical cancers.
AI-generated by Semantic Scholar
Authors
Ruixin Liu, Zhanyu Lin, Yuelin Li, Yuetong Ci, Zhengqi Guo, Zhenguo Xu